Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) declared a dividend on Friday, March 14th, NASDAQ Dividends reports. Shareholders of record on Friday, April 11th will be paid a dividend of 0.2909 per share on Thursday, June 5th. The ex-dividend date is Friday, April 11th. This is a 51.9% increase from Reckitt Benckiser Group's previous dividend of $0.19.
Reckitt Benckiser Group Stock Performance
OTCMKTS RBGLY traded down $0.16 during trading on Wednesday, reaching $13.33. The company's stock had a trading volume of 360,654 shares, compared to its average volume of 310,899. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. The firm has a 50 day moving average price of $13.04 and a 200 day moving average price of $12.51. Reckitt Benckiser Group has a 12 month low of $10.24 and a 12 month high of $14.10.
Analysts Set New Price Targets
A number of equities research analysts have recently weighed in on the stock. Hsbc Global Res upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, December 11th. Royal Bank of Canada reaffirmed an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Barclays downgraded shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, February 4th. Finally, HSBC upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research report on Wednesday, December 11th. Three investment analysts have rated the stock with a hold rating, two have issued a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat.com, Reckitt Benckiser Group presently has an average rating of "Buy".
Get Our Latest Report on Reckitt Benckiser Group
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
